Intractable hyperkalemia due to nicorandil induced potassium channel syndrome

Ann Card Anaesth. 2015 Jan-Mar;18(1):101-3. doi: 10.4103/0971-9784.148331.

Abstract

Nicorandil is a commonly used antianginal agent, which has both nitrate-like and ATP-sensitive potassium (K ATP ) channel activator properties. Activation of potassium channels by nicorandil causes expulsion of potassium ions into the extracellular space leading to membrane hyperpolarization, closure of voltage-gated calcium channels and finally vasodilatation. However, on the other hand, being an activator of K ATP channel, it can expel K + ions out of the cells and can cause hyperkalemia. Here, we report a case of nicorandil induced hyperkalemia unresponsive to medical treatment in a patient with diabetic nephropathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Calcium Channels / metabolism
  • Cardiac Surgical Procedures
  • Coronary Stenosis / surgery
  • Coronary Vasospasm / prevention & control
  • Diabetic Nephropathies / complications
  • Humans
  • Hyperkalemia / blood
  • Hyperkalemia / chemically induced*
  • Male
  • Nicorandil / adverse effects*
  • Nicorandil / therapeutic use
  • Postoperative Complications / prevention & control
  • Potassium / metabolism
  • Potassium Channel Blockers / adverse effects*
  • Potassium Channel Blockers / therapeutic use

Substances

  • Calcium Channels
  • Potassium Channel Blockers
  • Nicorandil
  • Potassium